Deflazacort(Emflaza)
Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection
Reference price:
Manufacturer:
PTC THERAP
Formulation:
TABLET
Validity period:
24 months
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Emflaza(Deflazacort) Instructions:Uses,Dosage, Side Effects

EMFLAZA is a prescription drug with the active ingredient deflazacort, a corticosteroid prodrug. It is marketed under the brand name EMFLAZA and is available in two primary dosage forms: immediate-release tablets and an oral suspension. The tablets come in four strengths (6 mg, 18 mg, 30 mg, and 36 mg), while the oral suspension has a concentration of 22.75 mg per mL. This medication is specifically developed for a chronic neuromuscular condition.

Generic name

Deflazacort(Emflaza)
English name
Deflazacort
Alternative Names
Emflaza
Drug prices
Indications

EMFLAZA is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.

Therapeutic Target
Glucocorticoid receptor
Active Ingredients
Deflazacort
Dosage form
TABLET
specifications
6mg * 100 tablets/box
Description
Dosage and Administration

The recommended oral dosage is approximately 0.9 mg/kg once daily.

RECOMMENDED ARTICLES
RELATED ARTICLES
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved